Evotec SE today announced that BofA Securities and Morgan Stanley, as representatives of the several underwriters, notified Evotec of the underwriters’ exercise of their option to purchase up to 3,000,000 additional ADSs, representing 1,500,000 ordinary shares at the offering price of $ 21.75 per ADS. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-announces-the-exercise-of-the-greenshoe-option-6123
Cell Counting 101 Blog Giveaway
Cell Counting Formula Magnet Series
Wish you had all the cell counting formulas at your fingertips? Now you can with our Cell Counting 101 magnet series!
To get your hands on these useful magnets to put up in your lab, just post a comment on one of our Cell Counting 101 blogs. We’ll get in touch to ship one over to you. Every one of the four magnets has a unique formula, so each time you post a comment, you receive a different magnet to add to your collection*.
We urge you to get creative in the comments section—whether it’s a cell counting tip you’d like to share or a suggestion for our next blog topic, we’re looking forward to reading them.
See you on the blog!
* We’ll send you different magnets for each comment you leave, up to a maximum of four (4) magnets per person (i.e. the full series).
By Christina Psaradaki, Student Assistant at ChemoMetec
Christina Psaradaki studies Human Life Science Engineering at the Technical University of Denmark. At ChemoMetec, she writes for the Cell Counting Blog.
Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://chemometec.com/cell-counting-blog-magnet-giveaway/
Evotec SE reports results for the first nine months 2021 and provides corporate update
Evotec SE today announced the financial results and corporate updates for the first nine months 2021: Strong operational performance leads to significant revenue growth; co-owned pipeline gaining momentum; J.POD® Redmond (US) operational; successful Public Offering at NASDAQ (after period-end); guidance for full-year 2021 confirmed; webcast and conference Call today at 02.00 PM CET Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-reports-results-for-the-first-nine-months-2021-and-provides-corporate-update-6120
Evotec reaches programme designations in neuroscience collaboration with Bristol Myers Squibb
Evotec SE announced today that the Company reached additional programme designations within its neuroscience collaboration with Bristol Myers Squibb triggering payments of in total US$ 40 m to Evotec. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-reaches-programme-designations-in-neuroscience-collaboration-with-bristol-myers-squibb-6118
Evotec SE announces closing of public offering
Evotec SE announced today the closing of its public offering on 08 November 2021 in the United States of 20,000,000 American Depositary Shares (“ADSs”). Each ADS represents half of one ordinary share of Evotec. All ADSs sold in the offering were offered by Evotec at a public offering price of $ 21.75 per ADS. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-announces-closing-of-public-offering-6116
Symrise erhält Auszeichnung für soziales Engagement
— Sustainability Heroes Awards der Deutschen Gesellschaft für Nachhaltigkeit (DQS) verliehen
— Symrise-Projekte mit Lieferanten und lokalen Gemeinschaften gewürdigt Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-erhaelt-auszeichnung-fuer-soziales-engagement/
Evotec SE to announce results for the first nine months 2021 on 11 November 2021
Evotec SE will announce its financial results for the first nine months 2021 on Thursday, 11 November 2021. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-to-announce-results-for-the-first-nine-months-2021-on-11-november-2021-6112
Evotec SE Announces Placement of its Public Offering of American Depositary Shares
Evotec SE’s management board today decided – with the approval of its supervisory board – on the volume and the issue price of its public offering of American Depositary Shares (“ADSs”). The offering will produce gross proceeds of $ 435,000,000 from the sale of 10,000,000 ordinary shares of Evotec in the form of 20,000,000 ADSs at a price of $ 21.75 per ADS. Each ADS will represent one half of an ordinary share of Evotec. Accordingly, Evotec’s share capital, on the basis of Evotec’s articles of association (“Satzung”), will be increased to € 173,914,741,00 by issuing 10,000,000 shares from the authorized capital (“Genehmigtes Kapital 2021”) under exclusion of subscription rights of the existing shareholders (taking into account the subscription shares issued to date from conditional capital (“Bezugsaktien”), the actual share capital will then amount to € 175,110,695). Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/ad-hoc-releases/p/evotec-se-announces-placement-of-its-public-offering-of-american-depositary-shares-6114
Symrise schließt Joint Venture mit Groupe Neroli in der Region Grasse
— Nachhaltiges Wachstum und Diversifizierung des Portfolios natürlicher Rohstoffe
— Strategische Partnerschaft mit Schwerpunkt auf Blüten und mediterranen Pflanzen
— Unterstützung lokaler Landwirte und Einbringung von Parfümerie-Know-how Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-schliesst-joint-venture-mit-groupe-neroli-in-der-region-grasse/
Symrise Diana Food präsentiert neue Daten über den Zusammenhang von Immunsystem und Verdauung
— Webinar mit Vitafoods Insight für den 3. November 2021 geplant
— Verbindet wissenschaftliche Erkenntnisse mit Trends im Verbraucherverhalten
— Unterstreicht führende Rolle bei natürlichen Lösungen für Verdauung und Immunsystem Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-diana-food-praesentiert-neue-daten-ueber-den-zusammenhang-von-immunsystem-und-verdauung/